Cytokinetics, Incorporated (CYTK) NASDAQ
70.91
-2.77(-3.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.63B |
| Enterprise Value | 8.03B |
| P/E Ratio | -10.54 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 83.39 |
| Price/Book Ratio | -10.58 |
| Enterprise/Revenue | 92 |
| Enterprise/EBITDA | -13.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -7.84 |
| Operating Margin | -6.05 |
Management Effectiveness
| Return On Assets | -0.65 |
| Return On Equity | 1.4 |
Income Statement
| Revenue | 88.04M |
| Revenue/Share | 0.86 |
| Gross Profit | 77.91M |
| EBITDA | -775.27M |
| Net Income | -784.96M |
| Diluted EPS | -6.54 |
Balance Sheet
| Total Cash | 818.55M |
| Total Cash/Share | 6.64 |
| Total Debt | 1.04B |
| Total Debt/Equity | -1.26 |
| Current Ratio | 4.21 |
| Book Value Per Share | -6.71 |
Price History
| 52-Week Change | 127.2 |
| 52-Week High | 80.2 |
| 52-Week Low | 30.81 |
| Moving Average 50 Days | 68.88 |
| Moving Average 200 Days | 61.58 |
Statistics
| Average Volume | 2.44M |
| Shares Outstanding | 124.43M |
| % Held by Institutions | 121.7 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | June 25, 2013 |
